Navigation Links
Laerdal Medical and Medical Simulation Corporation Partner to Offer Integrated Training Courses for SimMan(R) Patient Simulators
Date:1/26/2010

WAPPINGERS FALLS, N.Y., Jan. 26 /PRNewswire/ -- Laerdal Medical Corporation today announced a new relationship with Medical Simulation Corporation (MSC), the recognized leader in providing full-service simulation training, education and consulting services to the healthcare industry, in which the companies will jointly offer simulation courseware designed to run on Laerdal's SimMan product family.

(Logo:  http://www.newscom.com/cgi-bin/prnh/20080325/NYTU018LOGO )

The courses, Moderate Sedation and Sepsis, help healthcare professionals across disciplines learn and develop the necessary skills to sedate patients or identify and treat patients at risk for developing sepsis in a safe, controlled environment that does not involve real patients.

Both courses offer Web-based curricula, simulation workshops, and simulation scenarios using Laerdal SimMan patient simulators. The courses were developed in response to the growing need in hospitals to address patient safety goals and quality initiatives driven by  The Joint Commission, the Agency for Healthcare Research and Quality and the Institute for Healthcare Improvement, among others.

The Moderate Sedation course is based on guidelines developed by The Joint Commission, American Society of Anesthesiologists and American Association of Nurse Anesthetists, and is suitable for any healthcare provider involved in the administration, assessment and monitoring of patients receiving moderate sedation medications. The Joint Commission requires that hospitals seeking to obtain or maintain accreditation have clear policies for administering moderate and deep sedation and that staff members have appropriate credentials.

The Sepsis program focuses on the early identification, treatment and long-term management of patients with sepsis, and is based on guidelines, tools and research from the Surviving Sepsis Campaign and the Institute for Healthcare Improvement. According to the Surviving Sepsis Web site, sepsis strikes an estimated 750,000 people in the U.S. alone, and is the leading cause of death for critically ill patients in this country. Mortality rates are unacceptably high, and the average cost of treating a patient with sepsis is estimated at $50,000.

"Our new relationship with Medical Simulation Corporation enables Laerdal to deliver comprehensive training solutions to healthcare customers looking to increase staff competence and confidence in delivering moderate sedation and treating patients at risk for developing sepsis," said Joseph Pahlow, vice president of sales, Laerdal. "Hospitals nationwide are increasing their focus on enhancing patient safety and reducing risk, and these courses, with the SimMan simulator the scenarios run on, will help them achieve those goals."

About Medical Simulation Corporation

Medical Simulation Corporation (MSC) is the recognized healthcare industry leader in providing full-service simulation training and education services to healthcare personnel, medical societies and medical product manufacturers. MSC's patient safety solutions are designed to strengthen the competence and confidence of nurses, physicians and technologists. Through its network of training platforms, MSC can provide customized training services to any location worldwide. For more information, please visit www.medsimulation.com or call 888-889-5882.

About Laerdal Medical Corporation

Laerdal Medical, one of the world's leading providers of Healthcare Solutions, is dedicated to helping save lives with products and services for Simulation, Airway Management, Immobilization, Basic Life Support, Advanced Life Support, Patient Care, Self-Directed Learning, and Medical Education. Laerdal is pleased to serve all healthcare providers and educators, from the lay rescuer to the medical professional. For more information, visit http://www.laerdal.com or call 877-523-7325.

Contact:  Wendy Troncone, +1-845-297-7770, wendy.troncone@laerdal.com

SOURCE Laerdal Medical Corporation

RELATED LINKS
http://www.laerdal.com
http://www.medsimulation.com

'/>"/>

SOURCE Laerdal Medical Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
2. You May Have a Thyroid Problem and Not Know It - Particularly If Youre Over 60, Says a New Harvard Medical School Report
3. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
4. Globus Medical Raises $110 Million in Series E Financing Round
5. Quark Pharmaceuticals Appoints New Chief Medical Officer
6. Boston University Biomedical Engineers Find Chink in Bacterias Armor
7. Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial
8. Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study
9. Flexible Medical Systems Raises $1.2M Seed Investment for Initial Human Trials
10. Cleveland Clinic Summits to Focus on Cardiovascular Medical Innovation
11. Rockwell Medical Technologies, Inc. Begins Dosing Patients for SFP Phase IIb Clinical Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... , April 29, 2016 ... Review, H1 2016" market research report that provides ... with comparative analysis at various stages, therapeutics assessment ... of administration (RoA) and molecule type, along with ... It also reviews key players involved in the ...
(Date:4/28/2016)... FLINT, Mich. , April 28, 2016 /PRNewswire/ ... transaction . Diplomat Pharmacy, Inc. (NYSE: DPLO), the ... it has signed a definitive agreement to acquire ... Advanced Specialty Pharmacy ("TNH"), a leading specialty pharmacy ... Van Nuys, California . In 2015, ...
(Date:4/28/2016)... , April 28, 2016  The blood testing market ... dollars, according to Kalorama Information and The Freedonia Group ... and nucleic acid testing.  The healthcare research firm said ... in developing blood collection stations and in improving testing ... Kalorama Information,s report, Blood Testing Market in ...
Breaking Medicine Technology:
(Date:5/2/2016)... ... May 02, 2016 , ... One of Hollywood’s best kept secrets ... Surgery & Laser Center, in Milford, Penn. “Patients with busy lives want noninvasive options ... treated and go home or back to work without having to wear recovery garments ...
(Date:5/2/2016)... ... ... Marshall Votta, Josh Holmes and Laura Sandman have joined RowdMap, Inc. and ... market growth across both health plans and provider organizations who use government benchmark data ... care. , Marshall Votta joins RowdMap, Inc. as Chief Market Officer and takes a ...
(Date:5/1/2016)... ... , ... Women's Excellence in Wellness, powered by Movestrong, will be holding Aroma ... Living Gold Member. , The class will be held Tuesday, May 24th from 6:30pm ... the Oils that can benefit participant's yoga practice, as well as overall health and ...
(Date:5/1/2016)... ... ... Outdoor Growing Bans Are Sweeping California, which states are next? , California, ... hands of the local communities to decide each county’s fate on growing and ... on growing regulations by 3/1/2016 or be forced to follow how the state decides ...
(Date:4/30/2016)... ... April 30, 2016 , ... Create an abstract shape ... distort and manipulate three-dimensional shapes with ease all within Apple Motion . ... polygons, polygon texture animation, opacity texture animation, overall shape texture displacement, twist, camera ...
Breaking Medicine News(10 mins):